In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy

European Radiology

Volumn 22, Issue 5, 2012, Pages 1131-1139

  Russo, F ^a   Mazzetti, S ^a   Grignani, G ^a   De Rosa, G ^a   Aglietta, M ^a   Anselmetti, G C ^a   Stasi, M ^a   Regge, D ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Choline peak; Magnetic resonance spectroscopy; Mitotic index; Single echo time; Soft tissue tumor

Indexed keywords

CHOLINE;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CHONDROSARCOMA; CLINICAL ARTICLE; DERMATOFIBROSARCOMA PROTUBERANS; DESMOID TUMOR; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; FEMALE; FIBROMATOSIS; FIBROSARCOMA; HEMANGIOMA; HEMANGIOMATOSIS; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; IN VIVO STUDY; LEIOMYOSARCOMA; LIPOMA; LIPOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; METASTATIC MELANOMA; MITOSIS; MYELOLIPOMA; MYXOSARCOMA; NEURILEMOMA; NEUROECTODERM TUMOR; NEUROFIBROMA; NONHODGKIN LYMPHOMA; OSSIFYING MYOSITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOCYST; RHABDOMYOSARCOMA; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; SOLITARY FIBROUS TUMOR; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHOLINE; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861527016     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2350-9     Document Type: Article

References (53)

1. Weiss SW, Goldblum JR (2001) Enzinger and Weiss's soft tissue tumors, 4th edn. Mosby-Harcourt Brace Company, St. Louis, MO, USA
2. Papagelopoulos PJ, Mavrogenis AF, Badekas A et al (2003) Foot malignancies: a multidisciplinary approach. Foot Ankle Clin 8:751-763 (Pubitemid 38759099)
3. Moulton JS, Blebea JS, Dunco DM et al (1995) MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR Am J Roentgenol 164:1191-1199
4. Campanacci M (1999) Bone and soft tissue tumors: clinical features, imaging, pathology and treatment, 2nd edn. Springer- Verlag, New York
5. Berquist TH, Ehman AL, Richardson ML (1987) Magnetic resonance of the musculoskeletal system. Raven, New York
6. Wetzel LH, Levine E (1990) Soft tissue tumors of the foot: value of MR imaging for specific diagnosis. AJR Am J Roentgenol 155:1025-1030 (Pubitemid 20357003)
7. Berquist TH, Ehman RL, King BF et al (1990) Value ofMR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR Am J Roentgenol 155:1251-1255
8. Arkun R, Memis A, Akalin T et al (1997) Liposarcoma of soft tissue: MRI findings with pathologic correlation. Skeletal Radiol 26:167-172 (Pubitemid 27143984)
9. Crim JR, Seeger LL, Yao L et al (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581-586
10. Verstraete KL, De Deene Y, Roels H et al (1994) Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 192:835-843
11. Fletcher BD, Reddick WE, Taylor JS et al (1996) Dynamic MR imaging of musculoskeletal neoplasms. Radiology 200:869-872
12. Verstraete KL, Van der Woude HJ, Hogendoorn PC et al (1996) Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 6:311-321 (Pubitemid 126701461)
13. Verstraete KL, Van der Woude HJ (2001) Dynamic contrastenhanced magnetic resonance imaging. In: De Schepper AM (ed) Imaging of soft tissue tumors, 2nd edn. Springer, Berlin, pp 83-104
14. Van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW et al (2004) Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 233:493-502 (Pubitemid 39423810)
15. Verstraete KL, Dierick A, De Deene Y et al (1994) First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI. Magn Reson Imaging 12:687-702 (Pubitemid 24226662)
16. Payne GS, Leach MO (2006) Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. Br J Radiol 79: S16-S26 (Pubitemid 44614400)
17. Gupta RK, Cloughesy TF, Sinha U et al (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neuro-Oncol 50:215-226 (Pubitemid 32192873)
18. Doganay S, Altinok T, Alkan A et al (2011) The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Eur J Radiol 79:e33-e37
19. Wang CK, Li CW, Hsieh TJ et al (2004) Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 232:599-605
20. Delorme S,WeberMA (2006) Applications ofMRS in the evaluation of focal malignant brain lesions. Cancer Imaging 6:95-99
21. Swindle P, McCredie S, Russell P et al (2003) Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiology 228:144-151 (Pubitemid 36736082)
22. Cheng LL, Burns MA, Taylor JL et al (2005) Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65:3030-3034 (Pubitemid 40524579)
23. Ronen SM, Leach MO (2001) Breast imaging technology: imaging biochemistry - applications to breast cancer. Breast Cancer Res 3:36-40 (Pubitemid 32223651)
24. Katz-Brull R, Seger D, Rivenson-Segal D et al (2002) Enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res 62:1966-1970 (Pubitemid 34408439)
25. Fayad LM, Bluemke DA, McCarthy EF et al (2006) Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 23(1):23-28 (Pubitemid 43100714)
26. Fayad LM, Barker PB, Jacobs MA et al (2007) Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol 188:1513-1520 (Pubitemid 46866852)
27. World Medical Association (2000) Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, 5th rev. Edinburgh, Scotland
28. Bartella L, Morris EA, Dershaw DD et al (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 239:686-692 (Pubitemid 43830603)
29. Sardanelli F, Fausto A, Di Leo G et al (2009) In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol 192:1608-1617
30. Fayed N, Olmos S, Morales H et al (2006) Physical basis of magnetic resonance spectroscopy and its application to central nervous system diseases. Am J Appl Sci 3:1836-1845
31. Sijens PE, van den Bent MJ, Nowak PJ et al (1997) 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 37:222-225 (Pubitemid 27045394)
32. Roebuck JR, Cecil KM, Schnall MD et al (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269-275 (Pubitemid 28464677)
33. Baek HM, Chen JH, Yu HJ et al (2008) Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging 27:1114-1121 (Pubitemid 351614625)
34. Huang W, Fisher PR, Dulaimy K et al (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232:585-591 (Pubitemid 38971303)
35. WHO Classification of Tumours (2002) Pathology & genetics - Tumours of soft tissue and bone. IARC, Lyon
36. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Statist Med 17:857-872 (Pubitemid 28185165)
37. Royal College of Obstetricians and Gynaecologists (2002) The investigation and management of the small-for-gestational-age fetus, guideline no.31. RCOG, London
38. Dowdy S, Weardon S, Chilko D (2004) Statistics for research, 3rd edn. Wiley, New Jersey
39. Hashimoto K, Brownstein MH, Jakobiec FA (1974) Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch Dermatol 110:874-885
40. Brenner W, Schaefler K, Chhabra H et al (1975) Dermatofibrosarcoma protuberans metastatic to a regional lymph node. Report of a case and review. Cancer 36:1897-1902
41. Herminghaus S, Pilatus U, Möller-Hartmann W et al (2002) Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 15:385-392
42. Krouwer HGJ, Kim TA, Rand SD et al (1998) Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 19:1695-1703 (Pubitemid 30413761)
43. Bitsch A, Bruhn H, Vougioukas Vet al (1999) Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 20:1619-1627 (Pubitemid 29498612)
44. Parikh J, Hyare H, Saifuddin A (2002) The imaging features of post-traumatic Myositis Ossificans, with emphasis on MRI. Clin Radiol 57:1058-1066 (Pubitemid 35452740)
45. Manaster BJ, May DA, Disler DG (2007) Musculoskeletal Imaging, 3rd edn. Mosby Elsevier, Philadelphia
46. Blamire AM (2008) The technology of MRI - the next 10 years? Br J Radiol 81:601-617
47. Qayyum A (2009) MR spectroscopy of the liver: principles and clinical applications. RadioGraphics 29:1653-1664
48. Erturk SM, Alberich-Bayarri A, Herrmann KA et al (2009) Use of 3.0-T MR imaging for evaluation of the abdomen. RadioGraphics 29:1547-1563
49. Ricci E, Pitt A, Keller PJ et al (2000) Effect of voxel position on single-voxel MR spectroscopy findings. AJNR Am J Neuroradiol 21:367-37
50. Bolan PJ, Nelson MT, Yee D et al (2005) Imaging in breast cancer: magnetic resonance spectroscopy. Research 7:149-152 (Pubitemid 40872777)
51. Li BSY, Regal J, Gonen O (2001) SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields. Magn Reson Med 46:1049-1053 (Pubitemid 33104290)
52. Usenius JPR, Kauppinen RA, Vainio PA et al (1994) Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomo 18:705-713 (Pubitemid 24286359)
53. Manton DJ, Lowry M, Blackband SJ et al (1995) Determination of protonmetabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. NMR Biomed 8:104-112